AAPS PharmSciTech

, Volume 6, Issue 3, pp E444–E448 | Cite as

Solid-state fluorescence of the trihydrate phases of ampicillin and amoxicillin



The purpose of this work was to study the effects of crystal structure on the solid-state photoluminescence of the trihydrate phases of ampicillin and amoxicillin, and to contrast these spectra with analogous spectra obtained on the molecules dissolved in a solution phase. The polymorphic identity of the analytes was established using x-ray powder diffraction and Fourier transform infrared absorption spectroscopy, and the solid-state luminescence spectra obtained under ambient conditions. It was found that the solid-state excitation and emission spectra of ampicillin trihydrate and amoxicillin trihydrate were dominated by energy transfer and exciton effects, which were manifested as decreases in the energy of the excitation and emission bands of the solid-state systems relative to those of the free molecule in solution. The photoluminescence data revealed that in spite of the known structural similarity of ampicillin trihydrate and amoxicillin trihydrate, the magnitude of the Davydov splitting, and the degree of band energy shifting differed between the 2 systems. This finding indicates that the small differences in crystal structure existing between the 2 compounds leads to measurable differences in the patterns of energy transfer.


polymorphism fluorescence spectroscopy energy transfer exciton splitting 


  1. 1.
    McClure DS.Electronic Spectra of Molecules and Ions in Crystals. 1959.Google Scholar
  2. 2.
    Threlfall TL. Analysis of Organic Polymorphs—A Review.Analyst. 1995;120:2435–2460.CrossRefGoogle Scholar
  3. 3.
    Brittain HG. Spectral methods for the characterization of polymorphs and solvates.J Pharm Sci. 1997;86:405–412.CrossRefGoogle Scholar
  4. 4.
    Brittain HG, ed.Polymorphism in Pharmaceutical Solids. 1999; 227–278.Google Scholar
  5. 5.
    Bernstein J, ed.Polymorphism in Molecular Crystals. 2002;94–150.Google Scholar
  6. 6.
    Brittain HG. Fluorescence studies of the transformation of carbamazepine anhydrate form-III to its dihydrate phase.J Pharm Sci. 2004;93:375–383.CrossRefGoogle Scholar
  7. 7.
    Brittain HG, Elder BJ, Isbester PK, Salerno AH. Solid-state fluorescence studies of some polymorphs, of diflunisal.Pharm Res. 2005;22:999–1006.CrossRefGoogle Scholar
  8. 8.
    Ivashkiv E. In: Florey K. ed.Analytical Profiles of Drug Substances. 1973;1–61.Google Scholar
  9. 9.
    Bhattacharyya PK, Cort WM. In: Florey K, ed.Analytical Profiles of Drug Substances. 1978;19–41.Google Scholar
  10. 10.
    Bird AE. In: Brittain HG, ed.Analytical Profiles of Drug Substances and Excipients. 1994;1–52.Google Scholar
  11. 11.
    James MNG, Hall D, Hodgkin DC. Crystalline modifications of ampicillin: the trihydrate.Nature. 1968;220:168–170.CrossRefGoogle Scholar
  12. 12.
    Boles MO, Girven RJ. The structures of ampicillin: a comparison of the anhydrate and trihydrate forms.Acta Crystallogr. 1976;B32: 2279–2284.Google Scholar
  13. 13.
    Boles MO, Girven RJ, Gane PAC. The structures of amoxicillin trihydrate and a comparison with the structures of ampicillin.Acta Crystallogr. 1976;B34:461–466.Google Scholar
  14. 14.
    Frenkel JI. On the transformation of light into heat in solids.Phys Rev. 2003;37:151–158.Google Scholar
  15. 15.
    Davydov AS.Theory of Molecular Excitons. 1962.Google Scholar
  16. 16.
    Craig DP, Walmsley SH.Excitons in Molecular Crystals. 1968.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2005

Authors and Affiliations

  1. 1.Center for Pharmaceutical PhysicsMilford

Personalised recommendations